Jurgen Serth
Overview
Explore the profile of Jurgen Serth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Faraj Tabrizi P, Peters I, Schimansky I, Dubrowinskaja N, Reese C, Tezval H, et al.
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003666
Cadherins (calcium-dependent adhesion proteins) are important in cellular adhesion and may play a role in the development and progression of renal cell carcinoma (RCC). This study investigated changes in cadherin...
2.
Serth J, Peters I, Katzendorn O, Dang T, Moog J, Balli Z, et al.
Int J Mol Sci
. 2022 Oct;
23(19).
PMID: 36232491
Approximately 21% of patients with renal cell cancer (RCC) present with synchronous metastatic disease at the time of diagnosis, and metachronous metastatic disease occurs in 20-50% of cases within 5...
3.
Serth J, Peters I, Hill B, Hubscher T, Hennenlotter J, Klintschar M, et al.
Int J Mol Sci
. 2022 May;
23(10).
PMID: 35628134
Both age-dependent and age-independent alteration of DNA methylation in human tissues are functionally associated with the development of many malignant and non-malignant human diseases. TCGA-KIRC data were biometrically analyzed to...
4.
Katzendorn O, Peters I, Dubrowinskaja N, Moog J, Reese C, Tezval H, et al.
Cancers (Basel)
. 2022 Jan;
14(1).
PMID: 35008203
The detection of DNA methylation in primary tumor tissues could be relevant for early stratification of aggressive renal cell carcinomas (RCCs) as a basis for future personalized adjuvant therapy. Methylated...
5.
Katzendorn O, Peters I, Dubrowinskaja N, Tezval H, Faraj Tabrizi P, von Klot C, et al.
BMC Cancer
. 2021 Apr;
21(1):444.
PMID: 33882870
Background: DNA methylation is frequently observed in the development and progression of many human tumors as well as renal cell cancer (RCC). Tumor Associated Calcium Signal Transducer 2 (TACSTD2) participates...
6.
Serth J, Peters I, Dubrowinskaja N, Reese C, Albrecht K, Klintschar M, et al.
Clin Epigenetics
. 2020 Feb;
12(1):33.
PMID: 32070431
Background: While a considerable number of tumor-specific hypermethylated loci have been identified in renal cell cancer (RCC), DNA methylation of loci showing successive increases in normal, tumoral, and metastatic tissues...
7.
Faraj Tabrizi P, Mohebbi Tafrechi A, Peters I, Atschekzei F, Kuczyk M, Serth J, et al.
Adv Ther
. 2019 Nov;
37(1):288-299.
PMID: 31721113
Introduction: The corticotropin-releasing hormone (CRH) system, its receptors corticotropin-releasing hormone receptor 1 (CRHR1) and 2 (CRHR2), and its corresponding binding protein corticotropin-releasing hormone-binding protein (CRHBP) as well as the urocortin...
8.
DNA methylation of sarcosine dehydrogenase (SARDH) loci as a prognosticator for renal cell carcinoma
Mazdak M, Tezval H, Callauch J, Dubrowinskaja N, Peters I, Bokemeyer C, et al.
Oncol Rep
. 2019 Sep;
42(5):2159-2168.
PMID: 31545450
DNA methylation plays an important role in the genesis and progression of tumor diseases. To identify new DNA methylation markers possibly associated with the clinical characteristics of renal cell carcinoma...
9.
Peters I, Dubrowinskaja N, Hennenlotter J, Antonopoulos W, von Klot C, Tezval H, et al.
Oncol Rep
. 2018 Oct;
40(6):3861-3868.
PMID: 30272321
Recent studies have shown that NELL1 expression is silenced epigenetically in human renal cell cancer (RCC) tissues and in RCC cell lines. However, it remains unknown whether NELL1 promoter methylation...
10.
Nicklas A, Kramer M, Serth J, Hennenlotter J, Hupe M, Reimer D, et al.
Adv Ther
. 2018 Sep;
35(11):2054-2068.
PMID: 30232708
Introduction: There is an urgent need to identify patients with bladder cancer (BC) who are at high risk of recurrence or progression. Calgranulin A is a strong marker for muscle-invasive...